219 related articles for article (PubMed ID: 30950241)
21. Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis.
Bu J; Li H; Li XY; Liu LH; Sun W; Xiao T
Dis Markers; 2015; 2015():739469. PubMed ID: 26351404
[TBL] [Abstract][Full Text] [Related]
22. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
24. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hung CS; Wang SC; Yen YT; Lee TH; Wen WC; Lin RK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308939
[TBL] [Abstract][Full Text] [Related]
26. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
Wang Q; Liu F; Liu L
Medicine (Baltimore); 2017 May; 96(18):e6369. PubMed ID: 28471952
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and Clinicopathological Value of
Liang H; Xiong Z; Li Y; Kong W; Yao Z; Li R; Deng M; Hu K
Biomed Res Int; 2018; 2018():4621015. PubMed ID: 30079348
[No Abstract] [Full Text] [Related]
30. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
[TBL] [Abstract][Full Text] [Related]
32. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract][Full Text] [Related]
33. NY-ESO-1 expression in solid tumors predicts prognosis: A systematic review and meta-analysis.
Wang H; Chen D; Wang R; Quan W; Xia D; Mei J; Xu J; Liu C
Medicine (Baltimore); 2019 Nov; 98(48):e17990. PubMed ID: 31770209
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
[TBL] [Abstract][Full Text] [Related]
35. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
Li Y; Wei J; Xu C; Zhao Z; You T
PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
[TBL] [Abstract][Full Text] [Related]
37. Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis.
Li X; Sun J; Hu S
Wien Klin Wochenschr; 2017 Aug; 129(15-16):558-563. PubMed ID: 28364168
[TBL] [Abstract][Full Text] [Related]
38. microRNA-1297 Inhibits the Growth and Metastasis of Colorectal Cancer by Suppressing Cyclin D2 Expression.
Wang Y; Xue J; Kuang H; Zhou X; Liao L; Yin F
DNA Cell Biol; 2017 Nov; 36(11):991-999. PubMed ID: 28933597
[TBL] [Abstract][Full Text] [Related]
39. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
40. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis.
Liang C; Dong H; Miao C; Zhu J; Wang J; Li P; Li J; Wang Z
Oncotarget; 2018 Feb; 9(15):12323-12332. PubMed ID: 29552313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
